chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Asthenia, COVID-19, Chills
Clinical narrative: Dry cough; Loss of taste and smell; Loss of taste and smell; Weakness/felt like no energy; Headache; Fever; Chills; Fatigue; Tested positive for Covid-19; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (Tested positive for Covid-19), COUGH (Dry cough), AGEUSIA (Loss of taste and smell), ANOSMIA (Loss of taste and smell) and ASTHENIA (Weakness/felt like no energy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     no medical history information was reported.  Concomitant products included PARACETAMOL (TYLENOL) and VITAMINS NOS for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced COVID-19 (Tested positive for Covid-19). On an unknown date, the patient experienced COUGH (Dry cough), AGEUSIA (Loss of taste and smell), ANOSMIA (Loss of taste and smell), ASTHENIA (Weakness/felt like no energy), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, COVID-19 (Tested positive for Covid-19), COUGH (Dry cough), AGEUSIA (Loss of taste and smell), ANOSMIA (Loss of taste and smell), ASTHENIA (Weakness/felt like no energy), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Apr-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product included cough medicine  Treatment information was not provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue, Headache, Pyrexia, SARS-CoV-2 test
Clinical narrative: Dry cough; Loss of taste and smell; Loss of taste and smell; Weakness/felt like no energy; Headache; Fever; Chills; Fatigue; Tested positive for Covid-19; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (Tested positive for Covid-19), COUGH (Dry cough), AGEUSIA (Loss of taste and smell), ANOSMIA (Loss of taste and smell) and ASTHENIA (Weakness/felt like no energy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     no medical history information was reported.  Concomitant products included PARACETAMOL (TYLENOL) and VITAMINS NOS for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced COVID-19 (Tested positive for Covid-19). On an unknown date, the patient experienced COUGH (Dry cough), AGEUSIA (Loss of taste and smell), ANOSMIA (Loss of taste and smell), ASTHENIA (Weakness/felt like no energy), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, COVID-19 (Tested positive for Covid-19), COUGH (Dry cough), AGEUSIA (Loss of taste and smell), ANOSMIA (Loss of taste and smell), ASTHENIA (Weakness/felt like no energy), HEADACHE (Headache), PYREXIA (Fever), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Apr-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product included cough medicine  Treatment information was not provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Diarrhoea, Headache, Influenza like illness
Clinical narrative: flu-like symptoms; Appetite lost; diarrhea; rash; Myalgia; vomiting; fever; headache; chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), DECREASED APPETITE (Appetite lost), DIARRHOEA (diarrhea), RASH (rash) and MYALGIA (Myalgia) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), DECREASED APPETITE (Appetite lost), DIARRHOEA (diarrhea), RASH (rash), MYALGIA (Myalgia), VOMITING (vomiting), PYREXIA (fever), HEADACHE (headache) and CHILLS (chills). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), DECREASED APPETITE (Appetite lost), DIARRHOEA (diarrhea), RASH (rash), MYALGIA (Myalgia), VOMITING (vomiting), PYREXIA (fever), HEADACHE (headache) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Rash, Vomiting
Clinical narrative: flu-like symptoms; Appetite lost; diarrhea; rash; Myalgia; vomiting; fever; headache; chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), DECREASED APPETITE (Appetite lost), DIARRHOEA (diarrhea), RASH (rash) and MYALGIA (Myalgia) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms), DECREASED APPETITE (Appetite lost), DIARRHOEA (diarrhea), RASH (rash), MYALGIA (Myalgia), VOMITING (vomiting), PYREXIA (fever), HEADACHE (headache) and CHILLS (chills). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), DECREASED APPETITE (Appetite lost), DIARRHOEA (diarrhea), RASH (rash), MYALGIA (Myalgia), VOMITING (vomiting), PYREXIA (fever), HEADACHE (headache) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea
Clinical narrative: Diarrhea; Stomach pain; This spontaneous case was reported by a patient and describes the occurrence of DIARRHOEA (Diarrhea) and ABDOMINAL PAIN UPPER (Stomach pain) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B218) for COVID-19 vaccination.    Co-suspect product included non-company product depo for an unknown indication.    Concomitant products included CHLORPROMAZINE, DULOXETINE HYDROCHLORIDE (CYMBALTA), BUSPIRONE HYDROCHLORIDE (BUSPAR), ARIPIPRAZOLE (ABILIFY) and MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.   On 08-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient started depo (unknown route) at an unspecified dose. On 10-Apr-2021, the patient experienced DIARRHOEA (Diarrhea) and ABDOMINAL PAIN UPPER (Stomach pain). At the time of the report, DIARRHOEA (Diarrhea) and ABDOMINAL PAIN UPPER (Stomach pain) had resolved. gas medicine      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was taking depo shot concomitantly. Treatment included gas medicine for diarrhea and stomach pain.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site nodule, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch knot at the site of injection), VACCINATION SITE NODULE (Itchy knot at the site of injection), VACCINATION SITE PRURITUS (Itchy knot at the site of injection) and VACCINATION SITE ERYTHEMA (Red knot at the site of injection) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch knot at the site of injection), VACCINATION SITE NODULE (Itchy knot at the site of injection), VACCINATION SITE PRURITUS (Itchy knot at the site of injection) and VACCINATION SITE ERYTHEMA (Red knot at the site of injection). At the time of the report, VACCINATION SITE WARMTH (Warm to the touch knot at the site of injection), VACCINATION SITE NODULE (Itchy knot at the site of injection), VACCINATION SITE PRURITUS (Itchy knot at the site of injection) and VACCINATION SITE ERYTHEMA (Red knot at the site of injection) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided. Treatment include Benadryl cream and symptoms are ongoing.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Headache, Nasopharyngitis, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: tiny bit of a sore throat only first thing in the mornings; Stuffy nose; cough; a little bit of a headache off and on; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (tiny bit of a sore throat only first thing in the mornings), NASOPHARYNGITIS (Stuffy nose), COUGH (a bit of a cough, which is not bad cough) and HEADACHE (a little bit of a headache off and on) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No medical history information was provided by the reporter.  Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), MONTELUKAST SODIUM (SINGULAIR) and BARIATRIC ADVANTAGE ULTRA MULTI WITH IRON for an unknown indication.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (tiny bit of a sore throat only first thing in the mornings), NASOPHARYNGITIS (Stuffy nose), COUGH (a bit of a cough, which is not bad cough) and HEADACHE (a little bit of a headache off and on). At the time of the report, OROPHARYNGEAL PAIN (tiny bit of a sore throat only first thing in the mornings), NASOPHARYNGITIS (Stuffy nose), COUGH (a bit of a cough, which is not bad cough) and HEADACHE (a little bit of a headache off and on) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, SARS-CoV-2 test positive: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient got exposed from his 19 year old son & tested positive for Covid-19 . He thinks the symptoms are not related to first dose. Patient prefers to be contacted by phone.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No medical history information was provided by the reporter.     On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Headache, at an unspecified dose and frequency. On 13-Mar-2021, HEADACHE (Headache) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medication information was not provided by the reporter.  Treatment medication also included rubbing alcohol.   This case was linked to US-MODERNATX, INC.-MOD-2021-075023 (Patient Link).
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Malaise, Night sweats, Oropharyngeal pain, Pain
Clinical narrative: low fevers of 99.3 degrees which went up to 100 degrees; chills; had to go home from work, because he wasn't feeling well; having sweating, described as night sweats; slight soreness in his throat, which was not severe; soreness in his left arm; left nostril hurt; sinus pressure with a slight headache and aching near his left eye; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in his left arm), MALAISE (had to go home from work, because he wasn't feeling well), NIGHT SWEATS (having sweating, described as night sweats), OROPHARYNGEAL PAIN (slight soreness in his throat, which was not severe) and PAIN (left nostril hurt) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was provided by the reporter.     On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced PAIN (left nostril hurt) and PARANASAL SINUS DISCOMFORT (sinus pressure with a slight headache and aching near his left eye). On 06-Apr-2021, the patient experienced PAIN IN EXTREMITY (soreness in his left arm). On 07-Apr-2021, the patient experienced MALAISE (had to go home from work, because he wasn't feeling well), NIGHT SWEATS (having sweating, described as night sweats), OROPHARYNGEAL PAIN (slight soreness in his throat, which was not severe) and CHILLS (chills). On an unknown date, the patient experienced PYREXIA (low fevers of 99.3 degrees which went up to 100 degrees). The patient was treated with PARACETAMOL (TYLENOL) for Fever and Pain in arm, at an unspecified dose and frequency. On 08-Apr-2021, PAIN (left nostril hurt) and PARANASAL SINUS DISCOMFORT (sinus pressure with a slight headache and aching near his left eye) had resolved. On 11-Apr-2021, OROPHARYNGEAL PAIN (slight soreness in his throat, which was not severe) had resolved. At the time of the report, PAIN IN EXTREMITY (soreness in his left arm) had resolved, MALAISE (had to go home from work, because he wasn't feeling well) and PYREXIA (low fevers of 99.3 degrees which went up to 100 degrees) outcome was unknown and NIGHT SWEATS (having sweating, described as night sweats) and CHILLS (chills) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Paranasal sinus discomfort, Pyrexia, SARS-CoV-2 test
Clinical narrative: low fevers of 99.3 degrees which went up to 100 degrees; chills; had to go home from work, because he wasn't feeling well; having sweating, described as night sweats; slight soreness in his throat, which was not severe; soreness in his left arm; left nostril hurt; sinus pressure with a slight headache and aching near his left eye; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in his left arm), MALAISE (had to go home from work, because he wasn't feeling well), NIGHT SWEATS (having sweating, described as night sweats), OROPHARYNGEAL PAIN (slight soreness in his throat, which was not severe) and PAIN (left nostril hurt) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was provided by the reporter.     On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced PAIN (left nostril hurt) and PARANASAL SINUS DISCOMFORT (sinus pressure with a slight headache and aching near his left eye). On 06-Apr-2021, the patient experienced PAIN IN EXTREMITY (soreness in his left arm). On 07-Apr-2021, the patient experienced MALAISE (had to go home from work, because he wasn't feeling well), NIGHT SWEATS (having sweating, described as night sweats), OROPHARYNGEAL PAIN (slight soreness in his throat, which was not severe) and CHILLS (chills). On an unknown date, the patient experienced PYREXIA (low fevers of 99.3 degrees which went up to 100 degrees). The patient was treated with PARACETAMOL (TYLENOL) for Fever and Pain in arm, at an unspecified dose and frequency. On 08-Apr-2021, PAIN (left nostril hurt) and PARANASAL SINUS DISCOMFORT (sinus pressure with a slight headache and aching near his left eye) had resolved. On 11-Apr-2021, OROPHARYNGEAL PAIN (slight soreness in his throat, which was not severe) had resolved. At the time of the report, PAIN IN EXTREMITY (soreness in his left arm) had resolved, MALAISE (had to go home from work, because he wasn't feeling well) and PYREXIA (low fevers of 99.3 degrees which went up to 100 degrees) outcome was unknown and NIGHT SWEATS (having sweating, described as night sweats) and CHILLS (chills) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Pyrexia
Clinical narrative: flu-like symptoms; fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms) and PYREXIA (fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Positive) on 12-Dec-2020 and Transplant.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms) and PYREXIA (fever). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Tylenol.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pharyngeal swelling, Throat tightness
Clinical narrative: Swelling in throat; Outer jawwas numb; Tightness in throat; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (Swelling in throat), HYPOAESTHESIA (Outer jawwas numb) and THROAT TIGHTNESS (Tightness in throat) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (allergy to sulfa and antibiotics).    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced PHARYNGEAL SWELLING (Swelling in throat), HYPOAESTHESIA (Outer jawwas numb) and THROAT TIGHTNESS (Tightness in throat). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. On 13-Mar-2021, PHARYNGEAL SWELLING (Swelling in throat), HYPOAESTHESIA (Outer jawwas numb) and THROAT TIGHTNESS (Tightness in throat) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-075027 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075027:cross linked to Dose 2
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swelling at the injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 011A21A) for COVID-19 vaccination.     No medical history information was provide by the reporter.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced VACCINATION SITE SWELLING (swelling at the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Vaccination site pruritus and Vaccination site swelling, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE SWELLING (swelling at the injection site) was resolving. The swelling has gone down a bit at the time of the call (13Apr2021) but the itching is still ongoing. She took Tylenol.          Patient reported that swelling was gone at the time of call on 13Apr202 but itching is still ongoing from dose 2.  No concomitant medication was provided.   This case was linked to MOD-2021-075001 (Patient Link).
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood glucose decreased, Dizziness, Fatigue, Hypotension
Clinical narrative: Dizziness; unable to read labels; Inability to use any limbs including neck; could not talk; weakness; blood pressure low; blood sugar low; Sudden urge to urinate; Vision blurriness; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), VISUAL IMPAIRMENT (unable to read labels), MOVEMENT DISORDER (Inability to use any limbs including neck), SPEECH DISORDER (could not talk) and ASTHENIA (weakness) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045A20A and 042?21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Bipolar affective disorder. Concurrent medical conditions included Drug allergy (Bactrim, baclofen) and Penicillin allergy. Concomitant products included CLONAZEPAM (KLONOPIN) for Anxiety, TRAZODONE HYDROCHLORIDE (TRAZODONE) for Depression, LAMOTRIGINE (LAMICTAL) for Mood change, QUETIAPINE FUMARATE (SEROQUEL) for Psychosis, LISDEXAMFETAMINE MESILATE (VYVANSE) and MIRTAZAPINE for an unknown indication.   On 24-Mar-2021 at 12:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced DIZZINESS (Dizziness), VISUAL IMPAIRMENT (unable to read labels), MOVEMENT DISORDER (Inability to use any limbs including neck), SPEECH DISORDER (could not talk), ASTHENIA (weakness), HYPOTENSION (blood pressure low), BLOOD GLUCOSE DECREASED (blood sugar low), MICTURITION URGENCY (Sudden urge to urinate), VISION BLURRED (Vision blurriness) and FATIGUE (Fatigue). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 23-Mar-2021, DIZZINESS (Dizziness), VISUAL IMPAIRMENT (unable to read labels), MOVEMENT DISORDER (Inability to use any limbs including neck), SPEECH DISORDER (could not talk), ASTHENIA (weakness), HYPOTENSION (blood pressure low), BLOOD GLUCOSE DECREASED (blood sugar low), MICTURITION URGENCY (Sudden urge to urinate), VISION BLURRED (Vision blurriness) and FATIGUE (Fatigue) had resolved. Not Provided          This case was linked to MOD-2021-104721, MOD-2021-104721 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Second dose details and outcome of events after first dose, Concomitant medications with indication added
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Micturition urgency, Movement disorder, Speech disorder, Vision blurred, Visual impairment
Clinical narrative: Dizziness; unable to read labels; Inability to use any limbs including neck; could not talk; weakness; blood pressure low; blood sugar low; Sudden urge to urinate; Vision blurriness; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), VISUAL IMPAIRMENT (unable to read labels), MOVEMENT DISORDER (Inability to use any limbs including neck), SPEECH DISORDER (could not talk) and ASTHENIA (weakness) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045A20A and 042?21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Bipolar affective disorder. Concurrent medical conditions included Drug allergy (Bactrim, baclofen) and Penicillin allergy. Concomitant products included CLONAZEPAM (KLONOPIN) for Anxiety, TRAZODONE HYDROCHLORIDE (TRAZODONE) for Depression, LAMOTRIGINE (LAMICTAL) for Mood change, QUETIAPINE FUMARATE (SEROQUEL) for Psychosis, LISDEXAMFETAMINE MESILATE (VYVANSE) and MIRTAZAPINE for an unknown indication.   On 24-Mar-2021 at 12:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced DIZZINESS (Dizziness), VISUAL IMPAIRMENT (unable to read labels), MOVEMENT DISORDER (Inability to use any limbs including neck), SPEECH DISORDER (could not talk), ASTHENIA (weakness), HYPOTENSION (blood pressure low), BLOOD GLUCOSE DECREASED (blood sugar low), MICTURITION URGENCY (Sudden urge to urinate), VISION BLURRED (Vision blurriness) and FATIGUE (Fatigue). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 23-Mar-2021, DIZZINESS (Dizziness), VISUAL IMPAIRMENT (unable to read labels), MOVEMENT DISORDER (Inability to use any limbs including neck), SPEECH DISORDER (could not talk), ASTHENIA (weakness), HYPOTENSION (blood pressure low), BLOOD GLUCOSE DECREASED (blood sugar low), MICTURITION URGENCY (Sudden urge to urinate), VISION BLURRED (Vision blurriness) and FATIGUE (Fatigue) had resolved. Not Provided          This case was linked to MOD-2021-104721, MOD-2021-104721 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Second dose details and outcome of events after first dose, Concomitant medications with indication added
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm/arm hurting; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (sore arm/arm hurting) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 002B21A) for COVID-19 vaccination.     The patient's past medical history included Operation NOS (Had heart operation six years prior to reporting time.). Concurrent medical conditions included Drug allergy (Allergy to Sulfa). Concomitant products included LISINOPRIL, PRAVASTATIN and CLOPIDOGREL for an unknown indication.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm/arm hurting). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Pain in arm, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm/arm hurting) outcome was unknown.            This case was linked to US-MODERNATX, INC.-MOD-2021-075000 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Dry mouth, Pain in extremity
Clinical narrative: soreness in the arm; no saliva in mouth/mouth very dry; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in the arm) and DRY MOUTH (no saliva in mouth/mouth very dry) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness in the arm) and DRY MOUTH (no saliva in mouth/mouth very dry). At the time of the report, PAIN IN EXTREMITY (soreness in the arm) and DRY MOUTH (no saliva in mouth/mouth very dry) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.   Reporter did not allow further contact
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: arm soreness; receive vaccine by accident; he was scheduled for a different vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (receive vaccine by accident) and WRONG PRODUCT ADMINISTERED (he was scheduled for a different vaccine) in a 12-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (receive vaccine by accident) and WRONG PRODUCT ADMINISTERED (he was scheduled for a different vaccine). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm soreness). On 12-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (receive vaccine by accident) and WRONG PRODUCT ADMINISTERED (he was scheduled for a different vaccine) had resolved. At the time of the report, PAIN IN EXTREMITY (arm soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided.  No treatment medication information was given.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Dizziness, Headache, Influenza like illness
Clinical narrative: felt like he was getting the flu; sick to his stomach; soreness on his arm; dizzy; body hurt all over; chills; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (felt like he was getting the flu), ABDOMINAL DISCOMFORT (sick to his stomach), PAIN IN EXTREMITY (soreness on his arm), DIZZINESS (dizzy) and PAIN (body hurt all over) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical information was provided by the reporter.     On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (felt like he was getting the flu), ABDOMINAL DISCOMFORT (sick to his stomach), PAIN IN EXTREMITY (soreness on his arm), DIZZINESS (dizzy), PAIN (body hurt all over), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency and DIMENHYDRINATE (DRAMAMINE) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (felt like he was getting the flu), ABDOMINAL DISCOMFORT (sick to his stomach), PAIN IN EXTREMITY (soreness on his arm), DIZZINESS (dizzy), PAIN (body hurt all over), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pyrexia
Clinical narrative: felt like he was getting the flu; sick to his stomach; soreness on his arm; dizzy; body hurt all over; chills; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (felt like he was getting the flu), ABDOMINAL DISCOMFORT (sick to his stomach), PAIN IN EXTREMITY (soreness on his arm), DIZZINESS (dizzy) and PAIN (body hurt all over) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical information was provided by the reporter.     On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (felt like he was getting the flu), ABDOMINAL DISCOMFORT (sick to his stomach), PAIN IN EXTREMITY (soreness on his arm), DIZZINESS (dizzy), PAIN (body hurt all over), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency and DIMENHYDRINATE (DRAMAMINE) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (felt like he was getting the flu), ABDOMINAL DISCOMFORT (sick to his stomach), PAIN IN EXTREMITY (soreness on his arm), DIZZINESS (dizzy), PAIN (body hurt all over), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal sensation in eye, Diarrhoea, Erythema, Fatigue, Headache
Clinical narrative: headache; nervous feeling; extreme diarrhea; arm itching; blood pressure has been higher than usual; arm swollen/red; arm swollen/red; fatigue; clammy eyes; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), NERVOUSNESS (nervous feeling), DIARRHOEA (extreme diarrhea), ABNORMAL SENSATION IN EYE (clammy eyes) and PRURITUS (arm itching) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported).   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced ABNORMAL SENSATION IN EYE (clammy eyes). On 09-Apr-2021, the patient experienced HEADACHE (headache), NERVOUSNESS (nervous feeling), DIARRHOEA (extreme diarrhea), PRURITUS (arm itching), HYPERTENSION (blood pressure has been higher than usual), PERIPHERAL SWELLING (arm swollen/red), ERYTHEMA (arm swollen/red) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and ISOPROPANOL (RUBBING ALCOHOL) at a dose of 1 dosage form. On 11-Apr-2021, DIARRHOEA (extreme diarrhea) had resolved. At the time of the report, HEADACHE (headache), NERVOUSNESS (nervous feeling), ABNORMAL SENSATION IN EYE (clammy eyes), PRURITUS (arm itching), HYPERTENSION (blood pressure has been higher than usual), PERIPHERAL SWELLING (arm swollen/red), ERYTHEMA (arm swollen/red) and FATIGUE (fatigue) outcome was unknown.            No concomitant medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-075011 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075011:CROSSLINKED WITH DOSE 1
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Nervousness, Peripheral swelling, Pruritus
Clinical narrative: headache; nervous feeling; extreme diarrhea; arm itching; blood pressure has been higher than usual; arm swollen/red; arm swollen/red; fatigue; clammy eyes; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), NERVOUSNESS (nervous feeling), DIARRHOEA (extreme diarrhea), ABNORMAL SENSATION IN EYE (clammy eyes) and PRURITUS (arm itching) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported).   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced ABNORMAL SENSATION IN EYE (clammy eyes). On 09-Apr-2021, the patient experienced HEADACHE (headache), NERVOUSNESS (nervous feeling), DIARRHOEA (extreme diarrhea), PRURITUS (arm itching), HYPERTENSION (blood pressure has been higher than usual), PERIPHERAL SWELLING (arm swollen/red), ERYTHEMA (arm swollen/red) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and ISOPROPANOL (RUBBING ALCOHOL) at a dose of 1 dosage form. On 11-Apr-2021, DIARRHOEA (extreme diarrhea) had resolved. At the time of the report, HEADACHE (headache), NERVOUSNESS (nervous feeling), ABNORMAL SENSATION IN EYE (clammy eyes), PRURITUS (arm itching), HYPERTENSION (blood pressure has been higher than usual), PERIPHERAL SWELLING (arm swollen/red), ERYTHEMA (arm swollen/red) and FATIGUE (fatigue) outcome was unknown.            No concomitant medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-075011 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075011:CROSSLINKED WITH DOSE 1
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, SARS-CoV-2 test positive
Clinical narrative: didn't feel well; covid postive; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (didn't feel well) and SARS-COV-2 TEST POSITIVE (covid postive) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (didn't feel well) and SARS-COV-2 TEST POSITIVE (covid postive). At the time of the report, MALAISE (didn't feel well) and SARS-COV-2 TEST POSITIVE (covid postive) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient wanted to know if he needed to redo the vaccination and he preferred to be contact by phone  No concomitant medications were reported.   No treatment information was provided.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site rash, Vaccination site swelling, Vaccination site warmth
Clinical narrative: left arm rash, red, blotchy spots at injection and warm to the touch; injection site on the left arm was swollen; left arm rash, red, blotchy spots at injection and warm to the touch; left arm rash, red, blotchy spots at injection and warm to the touch; soreness that went away 2 to 3 day later; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness that went away 2 to 3 day later), VACCINATION SITE WARMTH (left arm rash, red, blotchy spots at injection and warm to the touch), VACCINATION SITE SWELLING (injection site on the left arm was swollen), VACCINATION SITE RASH (left arm rash, red, blotchy spots at injection and warm to the touch) and VACCINATION SITE ERYTHEMA (left arm rash, red, blotchy spots at injection and warm to the touch) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced PAIN IN EXTREMITY (soreness that went away 2 to 3 day later). On 12-Apr-2021, the patient experienced VACCINATION SITE WARMTH (left arm rash, red, blotchy spots at injection and warm to the touch), VACCINATION SITE SWELLING (injection site on the left arm was swollen), VACCINATION SITE RASH (left arm rash, red, blotchy spots at injection and warm to the touch) and VACCINATION SITE ERYTHEMA (left arm rash, red, blotchy spots at injection and warm to the touch). The patient was treated with HYDROCORTISONE (HYDROCORTISONE 1% IN ABSORBASE) ongoing from 12-Apr-2021 at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (soreness that went away 2 to 3 day later) had resolved and VACCINATION SITE WARMTH (left arm rash, red, blotchy spots at injection and warm to the touch), VACCINATION SITE SWELLING (injection site on the left arm was swollen), VACCINATION SITE RASH (left arm rash, red, blotchy spots at injection and warm to the touch) and VACCINATION SITE ERYTHEMA (left arm rash, red, blotchy spots at injection and warm to the touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient stated that pharmacist recommended Benadryl for the symptoms which she has not started. Patient also used cold pack as a part of treatment.  No concomitant medication information was provided.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia, Hypotonia, Muscular weakness, Ocular discomfort
Clinical narrative: Unable to move the left side of his mouth; Unable to close his eyes tightly; The muscle of the left side of his face is not as strong as the muscle of the right side of his face; The left side of his face is numb /It is like he received a Lidocaine shot; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPOTONIA (Unable to move the left side of his mouth), OCULAR DISCOMFORT (Unable to close his eyes tightly), MUSCULAR WEAKNESS (The muscle of the left side of his face is not as strong as the muscle of the right side of his face), HYPOAESTHESIA (The left side of his face is numb /It is like he received a Lidocaine shot) and HEADACHE (Headache) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0211321A) for COVID-19 vaccination.     Concurrent medical conditions included Headache (He was having headaches on and off before receiving the vaccine.).    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced HEADACHE (Headache). On 12-Apr-2021, the patient experienced HYPOTONIA (Unable to move the left side of his mouth), OCULAR DISCOMFORT (Unable to close his eyes tightly), MUSCULAR WEAKNESS (The muscle of the left side of his face is not as strong as the muscle of the right side of his face) and HYPOAESTHESIA (The left side of his face is numb /It is like he received a Lidocaine shot). At the time of the report, HYPOTONIA (Unable to move the left side of his mouth), OCULAR DISCOMFORT (Unable to close his eyes tightly), MUSCULAR WEAKNESS (The muscle of the left side of his face is not as strong as the muscle of the right side of his face), HYPOAESTHESIA (The left side of his face is numb /It is like he received a Lidocaine shot) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment information included paracetamol for headache.
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Hypoaesthesia, Pharyngeal swelling, Swelling face, Throat irritation
Clinical narrative: INCREASED SWELLING IN THROAT; swelling in face; itchiness in throat; metallic flavor in mouth; Increased Jaw numbness; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (INCREASED SWELLING IN THROAT), SWELLING FACE (swelling in face), THROAT IRRITATION (itchiness in throat), DYSGEUSIA (metallic flavor in mouth) and HYPOAESTHESIA (Increased Jaw numbness) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergic to Sulfa.) and Allergy to antibiotic.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced PHARYNGEAL SWELLING (INCREASED SWELLING IN THROAT), SWELLING FACE (swelling in face), THROAT IRRITATION (itchiness in throat), DYSGEUSIA (metallic flavor in mouth) and HYPOAESTHESIA (Increased Jaw numbness). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 10-Apr-2021, PHARYNGEAL SWELLING (INCREASED SWELLING IN THROAT), SWELLING FACE (swelling in face), THROAT IRRITATION (itchiness in throat), DYSGEUSIA (metallic flavor in mouth) and HYPOAESTHESIA (Increased Jaw numbness) had resolved.            No concomitant medications provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-075014 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075014:cross linked to Dose 1